Guo Qianqian, Wang Ting, Yang Yue, Gao Lanlan, Zhao Qiong, Zhang Wenzhou, Xi Tao, Zheng Lufeng
Department of Pharmacy, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, 127 Dongming Road, Zhengzhou 450003, People's Republic of China.
School of Life Science and Technology, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, People's Republic of China.
Mol Ther Nucleic Acids. 2020 Sep 4;21:527-541. doi: 10.1016/j.omtn.2020.06.018. Epub 2020 Jun 24.
Transcription factor Yin Yang 1 (YY1) is upregulated in multiple tumors and plays essential roles in tumor proliferation and metastasis. However, the function of YY1 in breast cancer stemness remains unclear. Herein, we found that YY1 expression was negatively correlated with the overall survival and relapse-free survival of breast cancer patients and positively correlated with the expression of stemness markers in breast cancer. Overexpression of YY1 increased the expression of stemness markers, elevated CD44CD24 cell sub-population, and enhanced the capacity of cell spheroid formation and tumor-initiation. In contrast, YY1 knockdown exhibited the opposite effects. Mechanistically, YY1 decreased microRNA-873-5p (miR-873-5p) level by recruiting histone deacetylase 4 (HDAC4) and HDAC9 to miR-873-5p promoter and thus increasing the deacetylation level of miR-873-5p promoter. Sequentially, YY1 activated the downstream PI3K/AKT and ERK1/2 pathways, which have been confirmed to be suppressed by miR-873-5p in our recent work. Moreover, the suppressed effect of YY1/miR-873-5p axis on the stemness of breast cancer cells was partially dependent on PI3K/AKT and ERK1/2 pathways. Finally, it was found that the YY1/miR-873-5p axis is involved in the chemoresistance of breast cancer cells. Our study defines a novel YY1/miR-873-5p axis responsible for the stemness of breast cancer cells.
转录因子阴阳1(YY1)在多种肿瘤中上调,并在肿瘤增殖和转移中发挥重要作用。然而,YY1在乳腺癌干性中的功能仍不清楚。在此,我们发现YY1表达与乳腺癌患者的总生存期和无复发生存期呈负相关,与乳腺癌干性标志物的表达呈正相关。YY1的过表达增加了干性标志物的表达,提高了CD44CD24细胞亚群水平,并增强了细胞球形成和肿瘤起始能力。相反,YY1敲低则表现出相反的效果。机制上,YY1通过招募组蛋白去乙酰化酶4(HDAC4)和HDAC9到miR-873-5p启动子上,从而降低miR-873-5p水平,进而增加miR-873-5p启动子的去乙酰化水平。随后,YY1激活下游PI3K/AKT和ERK1/2信号通路,在我们最近的研究中已证实这两条信号通路被miR-873-5p抑制。此外,YY1/miR-873-5p轴对乳腺癌细胞干性的抑制作用部分依赖于PI3K/AKT和ERK1/2信号通路。最后,发现YY1/miR-873-5p轴参与了乳腺癌细胞的化疗耐药性。我们的研究定义了一个负责乳腺癌细胞干性的新型YY1/miR-873-5p轴。